Context Therapeutics Inc. Ratios

Ratios Dec2020 Dec2021
Profitability
EBT Margin 489.00%16,485.15%
EBIT Margin 389.00%16,385.15%
EBITDA Margin 389.00%16,385.15%
Operating Margin 389.00%16,385.15%
Net Margin 489.00%16,485.15%
FCF Margin 156.47%13,697.83%
Leverage & Solvency
Interest Coverage Ratio -3.89-163.85
Times Interest Earned -3.89-163.85
Valuation
Enterprise Value 42.47M
Market Capitalization 42.47M
Return Ratios
Return on Sales 4.89%164.85%